Lv1
48 积分 2024-11-14 加入
HER2 testing: evolution and update for a companion diagnostic assay
7小时前
已完结
HER2 immunoreactivity in advanced non-p53abn endometrial carcinoma: Association with clinical features, prognosis, and molecular characteristics
10小时前
求助中
HER2 expression in an endometrial cancer cohort
1天前
已完结
Comparison of HER2 Scoring Systems in Endometrial Cancer
1天前
求助中
Breaking through the basement membrane barrier to improve nanotherapeutic delivery to tumours
8天前
已完结
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
14天前
已完结
Rationale for Investigation of Neoadjuvant Chemoimmunotherapy Before Chemoradiation in Unresectable Stage III Non–Small Cell Lung Cancer
14天前
已完结
Progress in immunotherapy for resectable head and neck squamous cell carcinoma
22天前
已完结
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
22天前
已完结
Validation of the Generic Version of China Health Related Outcomes Measures (CHROME‐G) among individuals with type 2 diabetes in China
22天前
已完结
皖公网安备34019202002308
